We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Cytogenetic Study of Ocular Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00344799
Recruitment Status : Recruiting
First Posted : June 27, 2006
Last Update Posted : September 13, 2017
Information provided by (Responsible Party):
Jonsson Comprehensive Cancer Center

Brief Summary:
Patients who are diagnosed with choroidal melanoma and undergo I-125 plaque or enucleation surgery consent to participate in the study. A tumor sample taken during surgery is studied in the lab for genetic features. These features and features of subjects' clinical course are recorded. Analysis of the data may identify genetic features that are indicative of prognostic factors including risk of metastasis.

Condition or disease
Choroidal Melanoma

Detailed Description:
The Jules Stein Eye Institute Ocular Melanoma Research Group is conducting cytogenetic studies of choroidal melanoma to improve the screening of biopsy samples of choroidal melanoma through cytogenetic analysis. Our goal is to identify molecular probes that specifically target regions of chromosomes that undergo changes characteristic of metastatic choroidal melanoma.

Study Type : Observational
Estimated Enrollment : 200 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Molecular and Cytogenetic Studies of Ocular Melanoma
Actual Study Start Date : January 8, 2005
Estimated Primary Completion Date : August 31, 2020
Estimated Study Completion Date : August 31, 2021

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients who have been diagnosed with ocular melanoma, and underwent melanoma treatment at our facility.

Inclusion Criteria:

  1. Patient with diagnosis of ocular melanoma
  2. Patient with local treatment plan for ocular melanoma- plaque brachytherapy or enucleation
  3. Patient 18 years of age or older
  4. Archival enucleation specimens with diagnosis of ocular melanoma

Exclusion Criteria:

  1. Patient who refuses local melanoma treatment
  2. Patient who refuses to participate in this study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00344799

Contact: Tara A McCannel, MD, PhD 310-206-7484 tmccannel@jsei.ucla.edu
Contact: Brenda Rangel 310 794-9962 Brangel@jsei.ucla.edu

United States, California
Jules Stein Eye Institute Recruiting
Los Angeles, California, United States, 90095
Contact: Brenda Rangel    310-794-9962    Brangel@jsei.ucla.edu   
Sponsors and Collaborators
Jonsson Comprehensive Cancer Center
Principal Investigator: Tara M McCannel, MD, PhD Jules Stein Eye Institute, UCLA
Study Director: Bradley R Straatsma, MD, JD Jules Stein Eye Institute, UCLA
Study Chair: Lynn Gordon, MD, PhD Jules Stein Eye Institute, UCLA
Study Chair: Ben Glasgow, MD Jules Stein Eye Institute, UCLA
Study Chair: Nagesh P Rao, PhD UCLA Pathology and Laboratory Medicine

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Jonsson Comprehensive Cancer Center
ClinicalTrials.gov Identifier: NCT00344799     History of Changes
Other Study ID Numbers: UCLA IRB#04-12-084
First Posted: June 27, 2006    Key Record Dates
Last Update Posted: September 13, 2017
Last Verified: September 2017

Keywords provided by Jonsson Comprehensive Cancer Center:
Choroidal Melanoma
Choroidal Malignant Melanoma
Ocular Melanoma
Uveal Melanoma

Additional relevant MeSH terms:
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms, Nerve Tissue
Nevi and Melanomas